within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G02C_OtherGynecologicals.G02CB03_Cabergoline;
model Cabergoline 
   extends Pharmacolibrary.Drugs.ATC.G.G02CB03;

  annotation(Documentation(
    info ="<html><body><p>Cabergoline is a long-acting dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemia and disorders associated with prolactin excess. It is also sometimes used off-label for Parkinson's disease. Cabergoline is approved and in clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers of both sexes after oral administration.</p><h4>References</h4><ol><li><p>Del Dotto, P, &amp; Bonuccelli, U (2003). Clinical pharmacokinetics of cabergoline. <i>Clinical pharmacokinetics</i> 42(7) 633–645. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200342070-00003&quot;>10.2165/00003088-200342070-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12844325/&quot;>https://pubmed.ncbi.nlm.nih.gov/12844325</a></p></li><li><p>Nakatsuka, A, et al., &amp; Nomoto, M (2006). Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson&#x27;s disease. <i>Journal of pharmacological sciences</i> 100(1) 59–64. DOI:<a href=&quot;https://doi.org/10.1254/jphs.fp0050711&quot;>10.1254/jphs.fp0050711</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16410677/&quot;>https://pubmed.ncbi.nlm.nih.gov/16410677</a></p></li><li><p>Andreotti, AC, et al., &amp; Pontiroli, AE (1995). Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers. <i>The Journal of clinical endocrinology and metabolism</i> 80(3) 841–845. DOI:<a href=&quot;https://doi.org/10.1210/jcem.80.3.7883840&quot;>10.1210/jcem.80.3.7883840</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7883840/&quot;>https://pubmed.ncbi.nlm.nih.gov/7883840</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Cabergoline;
